177 related articles for article (PubMed ID: 22891351)
1. STAT3 negatively regulates thyroid tumorigenesis.
Couto JP; Daly L; Almeida A; Knauf JA; Fagin JA; Sobrinho-Simões M; Lima J; Máximo V; Soares P; Lyden D; Bromberg JF
Proc Natl Acad Sci U S A; 2012 Aug; 109(35):E2361-70. PubMed ID: 22891351
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of cancers derived from thyroid follicular cells.
Fagin JA; Krishnamoorthy GP; Landa I
Nat Rev Cancer; 2023 Sep; 23(9):631-650. PubMed ID: 37438605
[TBL] [Abstract][Full Text] [Related]
3. The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer.
Amara CS; Kami Reddy KR; Yuntao Y; Chan YS; Piyarathna DWB; Dobrolecki LE; Shih DJH; Shi Z; Xu J; Huang S; Ellis MJ; Apolo AB; Ballester LY; Gao J; Hansel DE; Lotan Y; Hodges HC; Lerner SP; Creighton CJ; Sreekumar A; Zheng WJ; Msaouel P; Kavuri SM; Putluri N
Nat Commun; 2024 Feb; 15(1):1373. PubMed ID: 38355560
[TBL] [Abstract][Full Text] [Related]
4. The Role of STAT3 in Thyroid Cancer.
Sosonkina N; Starenki D; Park JI
Cancers (Basel); 2014 Mar; 6(1):526-44. PubMed ID: 24662939
[TBL] [Abstract][Full Text] [Related]
5. Aberrant sonic hedgehog signaling pathway and STAT3 activation in papillary thyroid cancer.
Dong W; Cui J; Tian X; He L; Wang Z; Zhang P; Zhang H
Int J Clin Exp Med; 2014; 7(7):1786-93. PubMed ID: 25126181
[TBL] [Abstract][Full Text] [Related]
6. An update on molecular biology of thyroid cancers.
Omur O; Baran Y
Crit Rev Oncol Hematol; 2014 Jun; 90(3):233-52. PubMed ID: 24405857
[TBL] [Abstract][Full Text] [Related]
7. STAT3 regulated ARF expression suppresses prostate cancer metastasis.
Pencik J; Schlederer M; Gruber W; Unger C; Walker SM; Chalaris A; Marié IJ; Hassler MR; Javaheri T; Aksoy O; Blayney JK; Prutsch N; Skucha A; Herac M; Krämer OH; Mazal P; Grebien F; Egger G; Poli V; Mikulits W; Eferl R; Esterbauer H; Kennedy R; Fend F; Scharpf M; Braun M; Perner S; Levy DE; Malcolm T; Turner SD; Haitel A; Susani M; Moazzami A; Rose-John S; Aberger F; Merkel O; Moriggl R; Culig Z; Dolznig H; Kenner L
Nat Commun; 2015 Jul; 6():7736. PubMed ID: 26198641
[TBL] [Abstract][Full Text] [Related]
8. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.
Grabner B; Schramek D; Mueller KM; Moll HP; Svinka J; Hoffmann T; Bauer E; Blaas L; Hruschka N; Zboray K; Stiedl P; Nivarthi H; Bogner E; Gruber W; Mohr T; Zwick RH; Kenner L; Poli V; Aberger F; Stoiber D; Egger G; Esterbauer H; Zuber J; Moriggl R; Eferl R; Győrffy B; Penninger JM; Popper H; Casanova E
Nat Commun; 2015 Mar; 6():6285. PubMed ID: 25734337
[TBL] [Abstract][Full Text] [Related]
9. Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics.
Adesoye T; Tripathy D; Hunt KK; Keyomarsi K
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339245
[TBL] [Abstract][Full Text] [Related]
10. Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma.
Zhang X; Zhong Y; Liu L; Jia C; Cai H; Yang J; Wu B; Lv Z
Cell Death Dis; 2023 Dec; 14(12):827. PubMed ID: 38092752
[TBL] [Abstract][Full Text] [Related]
11. Progranulin promoted the proliferation, metastasis, and suppressed apoptosis via JAK2-STAT3/4 signaling pathway in papillary thyroid carcinoma.
Dong Y; Tan H; Wang L; Liu Z
Cancer Cell Int; 2023 Sep; 23(1):191. PubMed ID: 37660003
[TBL] [Abstract][Full Text] [Related]
12. JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences.
Ott N; Faletti L; Heeg M; Andreani V; Grimbacher B
J Clin Immunol; 2023 Aug; 43(6):1326-1359. PubMed ID: 37140667
[TBL] [Abstract][Full Text] [Related]
13. Targeting Tumor Microenvironment Akt Signaling Represents a Potential Therapeutic Strategy for Aggressive Thyroid Cancer.
Mirshahidi S; Yuan IJ; Simental A; Lee SC; Peterson NR; Andrade Filho PA; Murry T; Duerksen-Hughes P; Yuan X
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982542
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.
Eng ZH; Abdullah MI; Ng KL; Abdul Aziz A; Arba'ie NH; Mat Rashid N; Mat Junit S
Front Endocrinol (Lausanne); 2022; 13():1039494. PubMed ID: 36686473
[TBL] [Abstract][Full Text] [Related]
15. Role of STAT3 Expression in Thyroid Cancer: A Meta-Analysis and Systematic Review Based on the Chinese Population.
Liang YN; Zhang Z; Song J; Yang F; Yang P
Evid Based Complement Alternat Med; 2022; 2022():1116535. PubMed ID: 35463085
[TBL] [Abstract][Full Text] [Related]
16. Oleyl Conjugated Histidine-Arginine Cell-Penetrating Peptides as Promising Agents for siRNA Delivery.
Sajid MI; Mandal D; El-Sayed NS; Lohan S; Moreno J; Tiwari RK
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456715
[TBL] [Abstract][Full Text] [Related]
17. Potential Refinement of Recurrence Score by pSTAT3 Status.
Grinshpun A; Cohen Y; Zick A; Kadouri L; Hamburger T; Nisman B; Allweis TM; Oprea G; Peretz T; Uziely B; Sonnenblick A
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327992
[TBL] [Abstract][Full Text] [Related]
18. Trefoil Factor 3 Inhibits Thyroid Cancer Cell Progression Related to IL-6/JAK/STAT3 Signaling Pathway.
Xin Y; Shang X; Sun X; Liu Y; Xu G; Xue G
Evid Based Complement Alternat Med; 2021; 2021():2130229. PubMed ID: 34567204
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits the viability, migration and invasion of papillary thyroid cancer cells by regulating the miR-301a-3p/STAT3 axis.
Liang Y; Kong D; Zhang Y; Li S; Li Y; Dong L; Zhang N; Ma J
Exp Ther Med; 2021 Aug; 22(2):875. PubMed ID: 34194553
[TBL] [Abstract][Full Text] [Related]
20. The two facets of gp130 signalling in liver tumorigenesis.
Schmidt-Arras D; Galun E; Rose-John S
Semin Immunopathol; 2021 Aug; 43(4):609-624. PubMed ID: 34047814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
